Physician profile
Mark S Rittenger
NPI 1528011004
$449.46
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $45.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $35.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.01 | 2019 | |
| Shire North American Group INC | $32.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $31.60 | 2019 | |
| Abbott Laboratories | $24.91 | 2019 | |
| Genzyme Corporation | $24.17 | 2019 | |
| Csl Behring | $22.67 | 2019 | |
| Advanced Respiratory, INC | $17.69 | 2020 | |
| United Therapeutics Corporation | $17.15 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.44 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.84 | 2019 | |
| Electromed, INC. | $15.84 | 2019 | |
| Allergan, INC. | $15.69 | 2020 | |
| Lundbeck LLC | $15.24 | 2019 | |
| Genentech USA, INC. | $14.98 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $14.19 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.73 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $13.38 | 2019 | |
| Circassia INC. | $13.02 | 2019 | |
| Ekos Corporation | $12.87 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.59 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Teleflex LLC | $11.64 | 2019 | |
| Gilead Sciences, INC. | $11.17 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rittenger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.